Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

William Bara‐Jimenez, Tzvetelina Dimitrova, Abdulah Sherzai, Antonella Favit, M.M. Mouradian, Thomas N. Chase

Open source

DOI
10.1002/mds.20124
Published
2004-04-21
Container
Movement Disorders
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/mds.20124,
  title = {Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease},
  author = {William Bara‐Jimenez and Tzvetelina Dimitrova and Abdulah Sherzai and Antonella Favit and M.M. Mouradian and Thomas N. Chase},
  year = {2004},
  journal = {Movement Disorders},
  doi = {10.1002/mds.20124},
  url = {https://doi.org/10.1002/mds.20124}
}

RIS

TY  - JOUR
TI  - Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease
AU  - William Bara‐Jimenez
AU  - Tzvetelina Dimitrova
AU  - Abdulah Sherzai
AU  - Antonella Favit
AU  - M.M. Mouradian
AU  - Thomas N. Chase
PY  - 2004
JO  - Movement Disorders
DO  - 10.1002/mds.20124
UR  - https://doi.org/10.1002/mds.20124
ER  - 

APA

Bara‐Jimenez, W., Dimitrova, T., Sherzai, A., Favit, A., Mouradian, M., & Chase, T. N. (2004). Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.20124

Source records